NO992468L - Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID - Google Patents

Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Info

Publication number
NO992468L
NO992468L NO992468A NO992468A NO992468L NO 992468 L NO992468 L NO 992468L NO 992468 A NO992468 A NO 992468A NO 992468 A NO992468 A NO 992468A NO 992468 L NO992468 L NO 992468L
Authority
NO
Norway
Prior art keywords
nsaids
treatment
composition
gastrointestinal disorders
containing bismuth
Prior art date
Application number
NO992468A
Other languages
English (en)
Norwegian (no)
Other versions
NO992468D0 (no
Inventor
Jonathan Davidson Kaunitz
Owen Rickford Carryl
Shin Tanaka
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992468D0 publication Critical patent/NO992468D0/no
Publication of NO992468L publication Critical patent/NO992468L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992468A 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID NO992468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
PCT/US1997/021462 WO1998022118A1 (en) 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Publications (2)

Publication Number Publication Date
NO992468D0 NO992468D0 (no) 1999-05-21
NO992468L true NO992468L (no) 1999-07-01

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992468A NO992468L (no) 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Country Status (7)

Country Link
EP (1) EP0941102A1 (hu)
CN (1) CN1238694A (hu)
CA (1) CA2271381A1 (hu)
HU (1) HUP9904073A3 (hu)
NO (1) NO992468L (hu)
TR (1) TR199901101T2 (hu)
WO (1) WO1998022118A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
EP1154771A4 (en) * 1999-02-26 2005-04-20 Nitromed Inc INHIBITORS OF THE PROTON NITROSIS AND NITROSYL PUMP, COMPOSITIONS AND METHODS OF USE
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PT1337525E (pt) * 2000-12-01 2011-09-01 Takeda Pharmaceutical Processo para a cristalização de (r)- ou (s)-lansoprazole
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
EP2596792A1 (en) 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
PT2262790T (pt) 2008-03-10 2017-07-18 Takeda Pharmaceuticals Co Cristal de composto de benzimidazole
KR20110079641A (ko) 2008-09-09 2011-07-07 아스트라제네카 아베 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
WO2023143573A1 (zh) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 含铋化合物在用于治疗疾病中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
EP0681476B1 (en) * 1991-11-22 1997-08-27 The Procter & Gamble Company Unit dose form of bismuth subsalicylate
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.

Also Published As

Publication number Publication date
CN1238694A (zh) 1999-12-15
HUP9904073A3 (en) 2000-04-28
HUP9904073A2 (hu) 2000-03-28
TR199901101T2 (xx) 1999-07-21
NO992468D0 (no) 1999-05-21
EP0941102A1 (en) 1999-09-15
CA2271381A1 (en) 1998-05-28
WO1998022118A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
NO992468L (no) Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID
NZ235877A (en) Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
NO992469L (no) Sammensetninger inneholdende vismut og NSAID samt ett eller fler anti-mikrobielle midler til behandling av gastrointestinale lidelser
DK0963200T3 (da) Præparater til inhibering af angiogenese omfattende thalidomid og et NSAID
DK0754176T3 (da) Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens
ES2161780T3 (es) Polimeros que ligan fosfato para administracion oral.
DK0862424T3 (da) Farmaceutiske præparater omfattende flurbiprofen
DK0600725T3 (da) Farmaceutiske præparater indeholdende en guanidinothiazolforbindelse og antacider
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
DK1024815T3 (da) Farmaceutisk sammensætning til oral administrering af molekylært iod
DK0705100T3 (da) Terapeutiske substituerede guanidiner
NO976048L (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
ATE106737T1 (de) Pharmazeutische zusammensetzungen zur behandlung gastrointestinaler störungen.
DK0697862T3 (da) Farmaceutiske sammensætninger og fremgangsmåder, hvor der anvendes isobutyramid til behandling af betaglobinlidelser
PL323617A1 (en) Pharmaceutical preparation for treating oestrogen-dependent carcinomas
NO954073L (no) Sammensetninger for inhibisjon, kontroll og regresjon av angiogenesen inneholdende hyaluronsyre og NSAID
TR199800421A2 (xx) Moenomisin grubu antibiyotiklerin bizmut tuzlar�.
DK554585D0 (da) Laegemiddel omfattende en forbindelse af mindst et immunotoxin og mindst en mannoseholdig polymer
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori
NO982562L (no) Sammensetning for behandling av smerte
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
FR2707455B1 (fr) Empêchement de la reproduction des insectes xylophages, moyens pour le traitement préventif du matériau bois mis en Óoeuvre.
DK374584D0 (da) Analgetikum
SE8504612D0 (sv) Analgetiska och antiinflammatoriska kompositioner innefattande difenhydramin och forfaranden for anvendning av dessa
RU94013463A (ru) Способ и композиция для лечения заболеваний желудка и двенадцатиперстной кишки и новые производные пге2

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application